Werewolf Therapeutics Inc (HOWL)
2.51
+0.17
(+7.26%)
USD |
NASDAQ |
Jun 27, 16:00
2.50
-0.01
(-0.40%)
After-Hours: 20:00
Werewolf Therapeutics Debt to Equity Ratio: 0.3352 for March 31, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.3352 |
| December 31, 2023 | 0.3531 |
| September 30, 2023 | 0.3489 |
| June 30, 2023 | 0.33 |
| Date | Value |
|---|---|
| March 31, 2023 | 0.3226 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.00 |
| June 30, 2022 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Jun 2022
0.3531
Maximum
Dec 2023
0.2112
Average
0.3263
Median
Debt to Equity Ratio Benchmarks
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 0.5332 |
| IGC Pharma Inc | 0.0187 |
| NovaBay Pharmaceuticals Inc | 6.294 |
| Protalix BioTherapeutics Inc | 0.6856 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 177.60M |
| Total Liabilities (Quarterly) | 60.01M |
| Shareholders Equity (Quarterly) | 117.59M |
| Current Ratio | 6.707 |
| Net Debt Paydown Yield | -2.81% |